Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?

Lancet · 2019

Last updated 2026-05-28

Journal	Lancet, 2019
Citations	2
Relative citation ratio	0.13
NIH percentile	9
Molecules	—
Conditions studied	Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction

Full record and abstract on PubMed 31186119 ↗